Yahoo Web Search

Search results

  1. May 20, 2022 · Neil Tabatznik | Founder | Tshemba Foundation | mail me | South Africa is not only the most unequal country in the world, it also does not care well enough for its weak and sick. Its inequitable access to healthcare is iniquitous in many parts of the developing world.

  2. www.tshembafoundation.org › news-posts › celebratingTshemba Foundation

    Tshemba welcomed its first volunteer in 2017, but our story truly begins back in 2014 on a game drive in Hoedspruit, South Africa. Our lead founder, Neil Tabatznik, was approached by the tracker of the drive to help with the slow build of his daughter’s satellite primary school. Neil agreed, but still wanted to do more.

  3. Neil Tabatznik is an executive producer. He is a co-founder of the Blue Ice Group and a co-owner of the Blue Lake Media Fund. He is also a co-owner of Toronto’s Bloor Hot Docs Cinema and serves on the board of Hot Docs and the Canadian Film Centre.

  4. ANTHONY SELWYN TABATZNIK is a Director from London. This person was born in August 1947, which was over 76 years ago. ANTHONY SELWYN TABATZNIK is British and resident in United Kingdom. This company officer is, or was, associated with at least 1 company roles. Their most recent appointment, in our records, was to ACTON HIGH STREET LIMITED on ...

  5. Neil Tabatznik's business email address is n**@tshembafoundation.org. What is Neil Tabatznik's HQ phone number? Neil Tabatznik's HQ phone number is +27 (0)845689081. What industry does Neil Tabatznik work in? Neil Tabatznik works in the Nonprofit Organization Management industry.

  6. The OSC also opened an investigation that month into two directors of the company – former chairman Julian Neil Tabatznik and Raymond Stone – who sold about $8-million worth of shares days before the company announced a $70-million financing in late January, 2018.

  7. Neil Tabatznik, Acting Chairman. Neil has been with CardioGenics since 2003. He is the Chairman, CEO of Arrow Pharmaceuticals Inc. Arrow Pharmaceuticals is part of a global generic drug company established in 2000, and has seen rapid growth from 0 to 700 million in 8 years.

  1. People also search for